27th Jul 2006 12:04
For immediate release 27 July 2006 Proteome Sciences Plc ("Proteome") Result of AGM The Board of Proteome announces that at its Annual General Meeting held todayall resolutions were duly passed.Notes to editors:Proteome Sciences plcProteome Sciences, a global leader in applied proteomics, uses high sensitivityproprietary technologies to detect differentially expressed proteins indiseases. The protein biomarkers discovered in body fluids or tissues arevalidated, developed and commercialised as diagnostic, prognostic ortherapeutic products through strategic alliances and out-licensing.Through its unique ProteoSHOP‚® toolbox, Proteome Sciences provides highsensitivity/high throughput proteomics solutions, including traditional twodimensional gel-based electrophoresis (2DE) and proprietary gel-free proteinsequence tag technologies (PST‚®, qPSTtm& TMT‚®), to major pharma, biotechnologyand diagnostic companies, to discover and exploit protein biomarkers.Sensitizer‚® chemical mass tags have been developed separately as a series ofstand-alone reagents.For further information please visit www.proteomics.com .Enquiries:Proteome Sciences plcChristopher Pearce, Chief Executive OfficerEmail: [email protected]: +44 (0)1932 865065Public Relations for Proteome SciencesIKON AssociatesAdrian ShawTel: +44 (0)1483 535102Mobile: +44 (0)797 9900733Email: [email protected] SCIENCES PLCRelated Shares:
Proteome